Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

RNA Aptamer Delivery through Intact Human Skin.

Lenn JD, Neil J, Donahue C, Demock K, Tibbetts CV, Cote-Sierra J, Smith SH, Rubenstein D, Therrien JP, Pendergrast PS, Killough J, Brown MB, Williams AC.

J Invest Dermatol. 2018 Feb;138(2):282-290. doi: 10.1016/j.jid.2017.07.851. Epub 2017 Sep 20.

PMID:
28942363
2.

Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans.

Smith SH, Jayawickreme C, Rickard DJ, Nicodeme E, Bui T, Simmons C, Coquery CM, Neil J, Pryor WM, Mayhew D, Rajpal DK, Creech K, Furst S, Lee J, Wu D, Rastinejad F, Willson TM, Viviani F, Morris DC, Moore JT, Cote-Sierra J.

J Invest Dermatol. 2017 Oct;137(10):2110-2119. doi: 10.1016/j.jid.2017.05.004. Epub 2017 Jun 6.

3.

Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions.

Olivry T, Mayhew D, Paps JS, Linder KE, Peredo C, Rajpal D, Hofland H, Cote-Sierra J.

J Invest Dermatol. 2016 Oct;136(10):1961-1969. doi: 10.1016/j.jid.2016.05.117. Epub 2016 Jun 21.

4.

Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin.

Smith SH, Peredo CE, Takeda Y, Bui T, Neil J, Rickard D, Millerman E, Therrien JP, Nicodeme E, Brusq JM, Birault V, Viviani F, Hofland H, Jetten AM, Cote-Sierra J.

PLoS One. 2016 Feb 12;11(2):e0147979. doi: 10.1371/journal.pone.0147979. eCollection 2016.

5.

IL-33 amplifies an innate immune response in the degenerating retina.

Xi H, Katschke KJ Jr, Li Y, Truong T, Lee WP, Diehl L, Rangell L, Tao J, Arceo R, Eastham-Anderson J, Hackney JA, Iglesias A, Cote-Sierra J, Elstrott J, Weimer RM, van Lookeren Campagne M.

J Exp Med. 2016 Feb 8;213(2):189-207. doi: 10.1084/jem.20150894. Epub 2016 Jan 11.

6.

Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation.

Bessa J, Meyer CA, de Vera Mudry MC, Schlicht S, Smith SH, Iglesias A, Cote-Sierra J.

J Autoimmun. 2014 Dec;55:33-41. doi: 10.1016/j.jaut.2014.02.012. Epub 2014 Apr 29.

PMID:
24786898
7.

Flt3L-mobilized dendritic cells bearing H2-Kbm1 apoptotic cells do not induce cross-tolerance to CD8+ T cells across a class I MHC mismatched barrier.

del Rio ML, Cote-Sierra J, Rodriguez-Barbosa JI.

Transpl Int. 2011 May;24(5):501-13. doi: 10.1111/j.1432-2277.2011.01220.x. Epub 2011 Jan 29.

8.

KU812 cells provide a novel in vitro model of the human IL-33/ST2L axis: functional responses and identification of signaling pathways.

Tare N, Li H, Morschauser A, Cote-Sierra J, Ju G, Renzetti L, Lin TA.

Exp Cell Res. 2010 Sep 10;316(15):2527-37. doi: 10.1016/j.yexcr.2010.04.007. Epub 2010 Apr 18.

PMID:
20406635
9.

Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis.

Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, Boyce JA, Martinez-A C, Marquez G, Goya I, Hamid Q, Fraser CC, Picarella D, Cote-Sierra J, Hodge MR, Gutierrez-Ramos JC, Kolbeck R, Coyle AJ.

J Immunol. 2007 Aug 1;179(3):1740-50.

10.

CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.

Soler D, Chapman TR, Poisson LR, Wang L, Cote-Sierra J, Ryan M, McDonald A, Badola S, Fedyk E, Coyle AJ, Hodge MR, Kolbeck R.

J Immunol. 2006 Nov 15;177(10):6940-51.

12.

Interleukin 2 plays a central role in Th2 differentiation.

Cote-Sierra J, Foucras G, Guo L, Chiodetti L, Young HA, Hu-Li J, Zhu J, Paul WE.

Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3880-5. Epub 2004 Mar 5.

13.

Stat5 activation plays a critical role in Th2 differentiation.

Zhu J, Cote-Sierra J, Guo L, Paul WE.

Immunity. 2003 Nov;19(5):739-48.

14.

Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Cote-Sierra J, Bredan A, Toldos CM, Stijlemans B, Brys L, Cornelis P, Segovia M, de Baetselier P, Revets H.

Infect Immun. 2002 Jan;70(1):240-8.

15.

A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination.

Cote-Sierra J, Jongert E, Bredan A, Gautam DC, Parkhouse M, Cornelis P, De Baetselier P, Revets H.

Gene. 1998 Oct 9;221(1):25-34.

PMID:
9852946

Supplemental Content

Loading ...
Support Center